Gene therapy in status epilepticus

Epilepsia

Volumn 54, Issue SUPPL. 6, 2013, Pages 43-45

  Walker, Matthew C ^a   Schorge, Stephanie ^a   Kullmann, Dimitri M ^a   Wykes, Robert C ^a   Heeroma, Joost H ^a   Mantoan, Laura ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Animal models; Epilepsia partialis continua; Optogenetics; Subcortical regions; Viral vector

Indexed keywords

GALANIN; GENE THERAPY AGENT; HALORHODOPSIN; LENTIVIRUS VECTOR; NEUROPEPTIDE Y; POTASSIUM CHANNEL KV1.1; TETANUS TOXIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; DNA VIRUS; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; EPISOME; EXCITABILITY; GENE EXPRESSION; GENERALIZED EPILEPSY; GENETIC MANIPULATION; INTERNEURON; LENTIVIRINAE; MOTOR CORTEX; MOTOR PERFORMANCE; MUTAGENESIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PYRAMIDAL NERVE CELL; TEMPORAL LOBE EPILEPSY; VIRAL GENE THERAPY; ANIMAL; BRAIN; DISEASE MODEL; GENE THERAPY; GENETICS; HUMAN; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STATUS EPILEPTICUS; ANIMAL MODELS; METHODOLOGY; OPTOGENETICS; REVIEW; SUBCORTICAL REGIONS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; GENETIC THERAPY; HUMANS; NEURONS; STATUS EPILEPTICUS;

ANIMAL MODELS; EPILEPSIA PARTIALIS CONTINUA; OPTOGENETICS; SUBCORTICAL REGIONS; VIRAL VECTOR;

EID: 84891512605     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12275     Document Type: Article

References (18)

1. Boison D. (2009) Adenosine augmentation therapies (AATs) for epilepsy: Prospect of cell and gene therapies. Epilepsy Res 85:131-141.
2. Chang P, Hashemi KS, Walker MC. (2011) A novel telemetry system for recording EEG in small animals. J Neurosci Methods 201:106-115.
3. Cockerell OC, Rothwell J, Thompson PD, Marsden CD, Shorvon SD. (1996) Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK. Brain 119(Pt 2):393-407.
4. Cope DW, Di Giovanni G, Fyson SJ, Orban G, Errington AC, Lorincz ML, Gould TM, Carter DA, Crunelli V. (2009) Enhanced tonic GABAA inhibition in typical absence epilepsy. Nat Med 15: 1392-1398.
5. Friedmann T, Roblin R. (1972) Gene therapy for human genetic disease? Science 175:949-955. Available at: Http://www.ncbi.nlm.nih.gov/pubmed/5061866. Accessed March 13, 2013).
6. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J. (2013) Gene therapy clinical trials worldwide to 2012-an update. J Gene Med 15:65-77.
7. Haberman RP, Samulski RJ, McCown TJ. (2003) Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med 9:1076-1080.
8. Hamil NE, Cock HR, Walker MC. (2012) Acute down-regulation of adenosine A(1) receptor activity in status epilepticus. Epilepsia 53:177-188.
9. Krook-Magnuson E, Armstrong C, Oijala M, Soltesz I. (2013) Ondemand optogenetic control of spontaneous seizures in temporal lobe epilepsy. Nat Commun 4:1376.
10. Mazarati AM, Liu H, Soomets U, Sankar R, Shin D, Katsumori H, Langel U, Wasterlain CG. (1998) Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci 18:10070-10077.
11. Nilsen KE, Walker MC, Cock HR. (2005) Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat. Epilepsia 46:179-187.
12. Noé F, Pool A-H, Nissinen J, Gobbi M, Bland R, Rizzi M, Balducci C, Ferraguti F, Sperk G, During MJ, Pitkänen A, Vezzani A. (2008) Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain 131(Pt 6):1506-1515.
13. Paz JT, Davidson TJ, Frechette ES, Delord B, Parada I, Peng K, Deisseroth K, Huguenard JR. (2013) Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat Neurosci 16:64-70.
14. Romano G. (2006) The controversial role of adenoviral-derived vectors in gene therapy programs: Where do we stand? Drug News Perspect 19:99-106.
15. Tønnesen J, Sørensen AT, Deisseroth K, Lundberg C, Kokaia M. (2009) Optogenetic control of epileptiform activity. Proc Natl Acad Sci USA 106:12162-12167.
16. Warnock JN, Daigre C, Al-Rubeai M. (2011) Introduction to viral vectors. Methods Mol Biol 737:1-25.
17. Wykes RC, Heeroma JH, Mantoan L, Zheng K, MacDonald DC, Deisseroth K, Hashemi KS, Walker MC, Schorge S, Kullmann DM. (2012) Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci Transl Med 4:161ra152.
18. Young D, Dragunow M. (1994) Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 58: 245-261.